Pfizer-backed biopharma company Imara files for IPO - (MarketWatch via NewsPoints Desk)

  • Pfizer-backed Imara filed initial public offering documents with the US Securities and Exchange Commission, outlining plans to raise $86.3 million, reported MarketWatch.

  • "We are a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from...hemoglobinopathies," the company stated.

  • Pfizer owns a stake in the company through its Pfizer Ventures investment arm, according to the news source.

To read more NewsPoints articles, click here.

Reference Articles